Coeptis Therapeutics, Inc. (COEP)
USD 9.75
(2.85%)
USD 9.75
(2.85%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -21.26 Million USD | 48.09% |
| 2022 | -40.96 Million USD | -184.06% |
| 2021 | -14.42 Million USD | -105.75% |
| 2020 | -7 Million USD | -313668.8% |
| 2019 | -2234.00 USD | 0.0% |
| 2005 | -344.3 Thousand USD | -113.0% |
| 2004 | 2.64 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -3.03 Million USD | -1.13% |
| 2024 Q1 | -3 Million USD | 20.08% |
| 2023 Q2 | -3.11 Million USD | 66.37% |
| 2023 Q1 | -9.25 Million USD | -225.6% |
| 2023 FY | -21.26 Million USD | 48.09% |
| 2023 Q4 | -3.75 Million USD | 40.02% |
| 2023 Q3 | -6.26 Million USD | -101.12% |
| 2022 Q4 | -2.84 Million USD | 50.38% |
| 2022 Q3 | -5.72 Million USD | 41.56% |
| 2022 Q2 | -9.8 Million USD | 100.0% |
| 2022 Q1 | -3408.57 Billion USD | -120036826.92% |
| 2022 FY | -40.96 Million USD | -184.06% |
| 2021 Q3 | -5.94 Million USD | -119.16% |
| 2021 FY | -14.42 Million USD | -105.75% |
| 2021 Q1 | -1.95 Million USD | -298.59% |
| 2021 Q2 | -2.71 Million USD | -39.13% |
| 2021 Q4 | -2.83 Million USD | 52.25% |
| 2020 FY | -7 Million USD | -313668.8% |
| 2020 Q4 | -489.23 Thousand USD | -3458.62% |
| 2020 Q3 | -13.74 Thousand USD | 0.0% |
| 2019 FY | -2234.00 USD | 0.0% |
| 2005 FY | -344.3 Thousand USD | -113.0% |
| 2005 Q1 | -32.00 USD | 0.0% |
| 2005 Q2 | -174.07 Thousand USD | -543896.88% |
| 2005 Q4 | -161.53 Thousand USD | -1757.52% |
| 2005 Q3 | -8696.00 USD | 95.0% |
| 2004 FY | 2.64 Million USD | 0.0% |
| 2004 Q4 | - USD | -100.0% |
| 2004 Q3 | 2.64 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -1492.485% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -204.554% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 140.141% |
| Nascent Biotech, Inc. | -2.08 Million USD | -918.667% |
| Rebus Holdings, Inc. | -1.02 Million USD | -1984.955% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 132.651% |
| Qrons Inc. | -789.34 Thousand USD | -2594.194% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -3262.793% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 66.027% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -5018.559% |
| Skye Bioscience, Inc. | -37.64 Million USD | 43.507% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 71.631% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -223.391% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -7678.486% |
| SQZ Biotechnologies Company | -79.46 Million USD | 73.238% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -635.257% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -1068.152% |
| Mesoblast Limited | -87.95 Million USD | 75.821% |
| Marizyme, Inc. | -65.34 Million USD | 67.456% |
| Genus plc | 7.9 Million USD | 369.197% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -95.254% |
| Pharming Group N.V. | -10.54 Million USD | -101.617% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -880.109% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -473.186% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -140.463% |
| ContraFect Corporation | -65.15 Million USD | 67.359% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -335.249% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -1131.091% |
| IMV Inc. | -36.48 Million USD | 41.713% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -163.863% |
| MultiCell Technologies, Inc. | -380.07 USD | -5595326.369% |
| ONE Bio Corp. | 8.67 Million USD | 345.102% |
| Accustem Sciences Inc. | -3.74 Million USD | -467.65% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 58.859% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -1578.318% |
| Q BioMed Inc. | -2.05 Million USD | -936.334% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -469.69% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -793.225% |
| Biomind Labs Inc. | -1.21 Million USD | -1651.314% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 64.393% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -585.626% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -169.091% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -991.012% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -141904.12% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -33.992% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -265.577% |
| GB Sciences, Inc. | -1.36 Million USD | -1461.79% |
| Alpha Cognition Inc. | -13.77 Million USD | -54.412% |
| HST Global, Inc. | -146.21 Thousand USD | -14445.2% |
| CSL Limited | 2.64 Billion USD | 100.805% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -1111.927% |
| Halberd Corporation | -79.67 Thousand USD | -26591.271% |
| Enzolytics Inc. | -2.17 Million USD | -876.949% |
| Agentix Corp. | -1.37 Million USD | -1447.545% |
| Resverlogix Corp. | -3.61 Million USD | -489.101% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -570.565% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 92.792% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 21800.548% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 407.116% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -435.277% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -602.762% |
| AVAX Technologies, Inc. | -6.41 Million USD | -231.583% |
| Zenith Capital Corp. | -10.59 Million USD | -100.703% |
| Genscript Biotech Corporation | -95.47 Million USD | 77.726% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -91400.46% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -412.949% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -35085.841% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -960.614% |
| Kadimastem Ltd | -3.3 Million USD | -542.999% |
| Helix BioMedix, Inc. | -1.05 Million USD | -1913.768% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -456.861% |
| BioStem Technologies, Inc. | -8.48 Million USD | -150.696% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -4718.312% |
| LadRx Corporation | 400.44 Thousand USD | 5410.753% |
| Cell Source, Inc. | -5.32 Million USD | -299.656% |
| Regen BioPharma, Inc. | 1.02 Million USD | 2177.809% |
| Regen BioPharma, Inc. | 1.02 Million USD | 2177.809% |
| NovAccess Global Inc. | -4.76 Million USD | -345.915% |
| Affymax, Inc. | -14.42 Million USD | -47.439% |
| Itoco Inc. | -1.86 Million USD | -1037.859% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -378.703% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -1174.208% |
| Mobile Lads Corp. | -2.26 Million USD | -839.629% |
| CytoDyn Inc. | -49.84 Million USD | 57.331% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -26808.427% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -9222.236% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -2158.724% |
| SYBLEU INC | -180.3 Thousand USD | -11694.823% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -1218.661% |
| International Stem Cell Corporation | -131 Thousand USD | -16133.998% |
| Bioxytran, Inc. | -4.28 Million USD | -396.881% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -39085.099% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -740.493% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 55.761% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -905.986% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -2623.382% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -571.292% |
| Neutra Corp. | -233.46 Thousand USD | -9009.09% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -4.808% |
| PureTech Health plc | -65.69 Million USD | 67.629% |
| IXICO plc | -1.17 Million USD | -1705.309% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -114.229% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 62.774% |
| CSL Limited | 2.64 Billion USD | 100.805% |
| Cellectis S.A. | -103.17 Million USD | 79.388% |